0001209191-19-050129.txt : 20190918 0001209191-19-050129.hdr.sgml : 20190918 20190918182815 ACCESSION NUMBER: 0001209191-19-050129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190916 FILED AS OF DATE: 20190918 DATE AS OF CHANGE: 20190918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EMPFIELD JAMES R. CENTRAL INDEX KEY: 0001665430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 191100655 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: VG5 48W ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-16 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001665430 EMPFIELD JAMES R. 200 - 3650 GILMORE WAY BURNABY A1 BRITISH COLUMBIA, CANADA 0 1 0 0 SVP, Drug Discovery Stock Option (Right to Buy) 9.44 2019-09-16 4 A 0 40000 0.00 A 2029-09-15 Common Shares 40000 40000 D Vesting over 36 months, in equal amounts, on the last day of each month. /s/ Sherry Aulin, Attorney-in-fact 2019-09-18